Premier Cancer Treatment throughout Arizona - Phoenix - Tucson - Chemotherapy, Radiation Therapy, Gynecologic, Clinical Research
Brio-Medical is a leading alternative cancer treatment center in Scottsdale, AZ. Meet Dr. Nathan Goodyear, the medical director, and explore our services.
current evidence, though limited, suggests reasonable tolerability with comparable efficacy in patients > 65 years old treated with immune-based therapies to that in younger controls; however, it is unclear if this leads to significant patient-relevant gains such as improved survival with an acce...
New Hope's Unlimited alternative cancer treatment is a unique combination of traditional, alternative, and holistic cancer therapies. We believe in treating the body's immune system and that any treatment should be unique to a person. Call us at 888-272-
New Hope's Unlimited alternative cancer treatment is a unique combination of traditional, alternative, and holistic cancer therapies. We believe in treating the body's immune system and that any treatment should be unique to a person. Call us at 888-272-
Carrot for Cancer treatment Carrot is one of the top anticancer herb. It is a nature’s gift to the mankind that helps in avoiding the painful western medical procedures like Chemotherapy and Radiation therapy. Carrots are a rich source of photo chemicals and antioxidants like Carotenoids, ...
Similarly, two patients with the same type of cancer may have distinct karyograms (see the diagram for an example), which means their treatments should be as unique as they are instead of a "one size fits all" treatment. This personalized genetic approach, rather than a generic approach, en...
This review discusses oncolytic viruses that are currently in preclinical and clinical trials for treatment of many types of cancer.
Intrahepatic cholangiocarcinoma (ICC) accounts for about 15% of primary liver cancer, and the incidence rate has been rising in recent years. Surgical resection is the best treatment for ICC, but the 5-year su... Authors: Huhu Zhang, Xiaolei Dong, Xiaoyan Ding, Guoxiang Liu, Fanghao Yang...
Finding targeted therapies for pancreatic cancer has long been an issue for pharma - but data from AZ/Merck & Co's Lynparza could change this.